4/20
09:00 am
snse
Sensei Biotherapeutics (SNSE) is now covered by Leerink Partners. They set an "outperform" rating and a $50.00 price target on the stock.
Medium
Report
Sensei Biotherapeutics (SNSE) is now covered by Leerink Partners. They set an "outperform" rating and a $50.00 price target on the stock.
4/9
07:30 am
snse
Sensei Biotherapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference
Medium
Report
Sensei Biotherapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference
3/30
07:38 am
snse
Sensei Biotherapeutics Reports Full Year 2025 Financial Results and Provides Corporate Update [Yahoo! Finance]
Medium
Report
Sensei Biotherapeutics Reports Full Year 2025 Financial Results and Provides Corporate Update [Yahoo! Finance]
3/30
07:30 am
snse
Sensei Biotherapeutics Reports Full Year 2025 Financial Results and Provides Corporate Update
Medium
Report
Sensei Biotherapeutics Reports Full Year 2025 Financial Results and Provides Corporate Update
3/17
06:00 am
snse
Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2/25
06:00 am
snse
Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)